p H-Sensitive Liposomes: Possible Clinical Implications
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
When p H-sensitive molecules are incorporated into liposomes, drugs can be specifically released from these vesicles by a change of p H in the ambient serum. Liposomes containing the p H-sensitive lipid palmitoyl homocysteine (PHC) were constructed so that the greatest p H differential (6.0 to 7.4) of drug release was obtained near physiological temperature. Such liposomes could be useful clinically if they enable drugs to be targeted to areas of the body in which p H is less than physiological, such as primary tumors and metastases or sites of inflammation and infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design of Liposomes for Enhanced Local Release of Drugs by Hyperthermia
Yatvin, M. B., Weinstein, J. N., Dennis, W. H., & Blumenthal, R. (1978) · Science · doi:10.1126/science.364652 · Cited by 956
Self-citationLiposome-Cell Interaction: Transfer and Intracellular Release of a Trapped Fluorescent Marker
Weinstein, J. N., Yoshikami, S., Henkart, P., Blumenthal, R., & Hagins, W. A. (1977) · Science · doi:10.1126/science.835007 · Cited by 699
Gregoriadis, G. (1977) · Nature · doi:10.1038/265407a0 · Cited by 390
Liposomes and Local Hyperthermia: Selective Delivery of Methotrexate to Heated Tumors
Weinstein, J. N., Magin, R. L., Yatvin, M. B., & Zaharko, D. S. (1979) · Science · doi:10.1126/science.432641 · Cited by 363
Self-citationProperties and Biological Effects of Liposomes and their uses in Pharmacology and Toxicology
Kimelberg, H. K., Mayhew, E. G., & Gregoriadis, G. (1978) · CRC Critical Reviews in Toxicology · doi:10.3109/10408447809029333 · Cited by 165
Modifications of the Acid-Base Status of the Internal Milieu of Tumors
(1965) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/34.6.857 · Cited by 153
USE OF LIPOSOMES FOR THE ENHANCEMENT OF THE CYTOTOXIC EFFECTS OF CYTOSINE ARABINOSIDE *
Mayhew, E. G., Papahadjopoulos, D., Rustum, Y. M., & Dave, C. (1978) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1978.tb22035.x · Cited by 70
Investigations on the pH of Malignant Tumours in Mice and Humans after the Administration of Glucose
Næslund, J., & Swenson, K. (1953) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016345309157588 · Cited by 58
pH studies of malignant tissues in human beings.
MEYER, K. A., & Kammerling, E. M. (1948) · PubMed · Cited by 56
Scherphof, G. L., Morselt, H. W. M., Regts, J., et al. (1979) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(79)90042-7 · Cited by 52
Cited by
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Impact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348
Therapeutic Nanoparticles for Drug Delivery in Cancer
Cho, K., Wang, X., Nie, S., Chen, Z. (., & Shin, D. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1441 · Cited by 2,920
Tenchov, R., Bird, R., Curtze, A. E., & Zhou, Q. (2021) · ACS Nano · doi:10.1021/acsnano.1c04996 · Cited by 2,221
Langer, R. (1990) · Science · doi:10.1126/science.2218494 · Cited by 1,778
New developments in liposomal drug delivery
Pattni, B. S., Chupin, V. V., & Torchilin, V. P. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00046 · Cited by 1,600
Ringsdorf, H., Schlarb, B., & Venzmer, J. (1988) · Angewandte Chemie International Edition in English · doi:10.1002/anie.198801131 · Cited by 1,454
Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities
Cheng, Z., Al Zaki, A., Hui, J. Z., Muzykantov, V. R., & Tsourkas, A. (2012) · Science · doi:10.1126/science.1226338 · Cited by 1,322
Danhier, F. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.015 · Cited by 1,288
Structure of the inverted hexagonal (HII) phase, and non-lamellar phase transitions of lipids
Seddon, J. M. (1990) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(90)90002-t · Cited by 1,089
Nanotechnology: Intelligent Design to Treat Complex Disease
Couvreur, P., & Vauthier, C. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0284-8 · Cited by 948
The relevance of tumour pH to the treatment of malignant disease
Wike-Hooley, J. L., Haveman, J., & Reinhold, H. S. (1984) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(84)80077-8 · Cited by 903
Biomedical Nanomagnetics: A Spin Through Possibilities in Imaging, Diagnostics, and Therapy
Krishnan, K. M. (2010) · IEEE Transactions on Magnetics · doi:10.1109/tmag.2010.2046907 · Cited by 819
Nanoparticles for drug delivery in cancer treatment
Haley, B., & Frenkel, E. (2008) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.03.015 · Cited by 791
Application of Nanotechnology in Cancer Therapy and Imaging
Wang, X., Yang, L., Chen, Z., & Shin, D. M. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0003 · Cited by 700
Nanotechnology in Therapeutics: A Focus on Nanoparticles as A Drug Delivery System
Bamrungsap, S., Zhao, Z., Chen, T., Wang, L., Li, C., Fu, T., & Tan, W. (2012) · Nanomedicine · doi:10.2217/nnm.12.87 · Cited by 606
Andresen, T. L., Jensen, S. S., & Jørgensen, K. (2005) · Progress in Lipid Research · doi:10.1016/j.plipres.2004.12.001 · Cited by 580
Current status of pH-sensitive liposomes in drug delivery
Drummond, D. C., Zignani, M., & Leroux, J.-C. (2000) · Progress in Lipid Research · doi:10.1016/s0163-7827(00)00011-4 · Cited by 477
Chemical Approaches to Triggerable Lipid Vesicles for Drug and Gene Delivery
Guo, X., & Szoka, F. C. (2003) · Accounts of Chemical Research · doi:10.1021/ar9703241 · Cited by 456
Polymeric nanoparticles for targeted treatment in oncology: current insights
Joshi, M. D., Patravale, V., & Prabhu, R. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s56932 · Cited by 438
Ringsdorf, H., Schlarb, B., & Venzmer, J. (1988) · Angewandte Chemie · doi:10.1002/ange.19881000111 · Cited by 399
Straubinger, R. M., Hong, K., Friend, D. S., & Papahadjopoulos, D. (1983) · Cell · doi:10.1016/0092-8674(83)90291-x · Cited by 393
Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures
Ragelle, H., Danhier, F., Préat, V., Langer, R., & Anderson, D. G. (2017) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1244187 · Cited by 390
Nanoparticles and its biomedical applications in health and diseases: special focus on drug delivery
Zahin, N., Anwar, R., Tewari, D., Kabir, M. T., Sajid, A., Mathew, B., Uddin, M. S., Aleya, L., & Abdel-Daim, M. M. (2020) · Environmental Science and Pollution Research · doi:10.1007/s11356-019-05211-0 · Cited by 371
Liposomal encapsulated anti-cancer drugs
Hofheinz, R.-D., Gnad-Vogt, S. U., Beyer, U., & Hochhaus, A. (2005) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000167902.53039.5a · Cited by 355
Synthetic Micelle Sensitive to IR Light via a Two-Photon Process
Goodwin, A. P., Mynar, J. L., Ma, Y., Fleming, G. R., & Fréchet, J. M. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0523035 · Cited by 352
Yao, C., Wang, P., Li, X., Hu, X., Hou, J., Wang, L., & Zhang, F. (2016) · Advanced Materials · doi:10.1002/adma.201503799 · Cited by 343
Polymeric Antitumor Agents on a Molecular and on a Cellular Level?
Gros, L., Ringsdorf, H., & Schupp, H. (1981) · Angewandte Chemie International Edition in English · doi:10.1002/anie.198103051 · Cited by 318
Mimicking the Cell: Bio-Inspired Functions of Supramolecular Assemblies
Tu, Y., Peng, F., Adawy, A., Men, Y., Abdelmohsen, L. K. E. A., & Wilson, D. A. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00344 · Cited by 316
Thermosensitive polymer-modified liposomes
Kono, K. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00204-6 · Cited by 303
Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development
Drummond, D. C., Noble, C. O., Hayes, M. E., Park, J. W., & Kirpotin, D. B. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21358 · Cited by 289
pH-sensitive liposomes: acid-induced liposome fusion.
Connor, J., Yatvin, M. B., & Huang, L. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.6.1715 · Cited by 287
Self-citationNanotechnology in Cancer Drug Delivery and Selective Targeting
Sutradhar, K. B., & Amin, M. L. (2014) · ISRN Nanotechnology · doi:10.1155/2014/939378 · Cited by 241
pH‐sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules
Straubinger, R. M., Düzgünes, N., & Papahadjopoulos, D. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)80210-6 · Cited by 240
Tunable pH-Sensitive Liposomes Composed of Mixtures of Cationic and Anionic Lipids
Hafez, I. M., Ansell, S., & Cullis, P. R. (2000) · Biophysical Journal · doi:10.1016/s0006-3495(00)76395-8 · Cited by 166
“Liposomes that can be triggered to release their contents or fuse in response to pH stimuli are of particular interest, as they can potentially respond to acidic environments in vivo (Yatvin et al., 1980; Straubinger, 1993).”
BackgroundHyperthermia can alter tumor physiology and improve chemo- and radio-therapy efficacy
Dunne, M., Regenold, M., & Allen, C. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.007 · Cited by 150
Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy
Muntimadugu, E., Kommineni, N., & Khan, W. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.010 · Cited by 82
A review on Stimuli-pH responsive liposomal formulation in cancer therapy
Jayapriya, P., Pardhi, E., Vasave, R., Guru, S. K., Madan, J., & Mehra, N. K. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.105172 · Cited by 24
Metadata
- Authors
- Yatvin, M. B., Kreutz, W., Horwitz, B. A., & Shinitzky, M.
- Venue
- Science
- Published
- 1980-12-12
- Volume
- 210
- Issue
- 4475
- Pages
- 1253-1255
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1984447304
- Cited by
- 415
- References
- 10
- FWCI
- 5.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.